171 related articles for article (PubMed ID: 22285105)
21. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor beta: an overview and update.
Zhao C; Dahlman-Wright K; Gustafsson JA
Nucl Recept Signal; 2008 Feb; 6():e003. PubMed ID: 18301783
[TBL] [Abstract][Full Text] [Related]
23. Sex hormone receptors in human thyroid tissues.
Miki H; Oshimo K; Inoue H; Morimoto T; Monden Y
Cancer; 1990 Oct; 66(8):1759-62. PubMed ID: 2208032
[TBL] [Abstract][Full Text] [Related]
24. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms.
Manole D; Schildknecht B; Gosnell B; Adams E; Derwahl M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1072-7. PubMed ID: 11238488
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines.
Somjen D; Grafi-Cohen M; Posner GH; Sharon O; Kraiem Z; Stern N
J Steroid Biochem Mol Biol; 2013 Jul; 136():80-2. PubMed ID: 23059472
[TBL] [Abstract][Full Text] [Related]
26. Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy.
Bershtein LM; Poroshina TE; Zimarina TS; Tsyrlina EV; Zhil'tsova EK; Kovalevskii AY; Semiglazov VF
Bull Exp Biol Med; 2004 Nov; 138(5):494-6. PubMed ID: 15723135
[TBL] [Abstract][Full Text] [Related]
27. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
Hall JM; McDonnell DP
Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
[TBL] [Abstract][Full Text] [Related]
28. Gene expression changes in rat prostate after activation or blocking of the androgen and estrogen receptor.
Nellemann C; Dalgaard M; Holst B; Bonefeld-Jørgensen EC; Vinggaard AM
Mol Cell Endocrinol; 2005 Jun; 237(1-2):25-35. PubMed ID: 15925091
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptors, antiestrogens, and non-small cell lung cancer.
Bogush TA; Dudko EA; Beme AA; Bogush EA; Kim AI; Polotsky BE; Tjuljandin SA; Davydov MI
Biochemistry (Mosc); 2010 Dec; 75(12):1421-7. PubMed ID: 21314611
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.
Antico-Arciuch VG; Dima M; Liao XH; Refetoff S; Di Cristofano A
Oncogene; 2010 Oct; 29(42):5678-86. PubMed ID: 20676139
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis of therapeutic strategies for breast cancer.
Huang J; Li X; Hilf R; Bambara RA; Muyan M
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):379-96. PubMed ID: 16375692
[TBL] [Abstract][Full Text] [Related]
32. Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma.
Bléchet C; Lecomte P; De Calan L; Beutter P; Guyétant S
Virchows Arch; 2007 Apr; 450(4):433-9. PubMed ID: 17333268
[TBL] [Abstract][Full Text] [Related]
33. Molecular target based combinational therapeutic approaches in thyroid cancer.
Rajoria S; Suriano R; George AL; Kamat A; Schantz SP; Geliebter J; Tiwari RK
J Transl Med; 2012 May; 10():81. PubMed ID: 22548798
[TBL] [Abstract][Full Text] [Related]
34. A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment.
Kimbro KS; Duschene K; Willard M; Moore JA; Freeman S
Mol Biol Rep; 2008 Mar; 35(1):23-7. PubMed ID: 17415682
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.
Ryan J; Ancelin ML
Drugs; 2012 Sep; 72(13):1725-38. PubMed ID: 22901010
[TBL] [Abstract][Full Text] [Related]
36. Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.
Božović A; Mandušić V; Todorović L; Krajnović M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562134
[TBL] [Abstract][Full Text] [Related]
37. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
[TBL] [Abstract][Full Text] [Related]
38. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
[TBL] [Abstract][Full Text] [Related]
39. Methylation of ERβ 5'-untranslated region attenuates its inhibitory effect on ERα gene transcription and promotes the initiation and progression of papillary thyroid cancer.
Xu LW; Gou X; Yang JY; Jiang R; Jiang X; Chen GG; Liu ZM
FASEB J; 2021 Apr; 35(4):e21516. PubMed ID: 33710697
[TBL] [Abstract][Full Text] [Related]
40. The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance.
Suba Z
Drug Des Devel Ther; 2015; 9():4341-53. PubMed ID: 26273195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
